Cytosurge elects veteran biotech executive, investor, and company builder Luba Greenwood, J.D., to its Board of Directors

Cytosurge appointed biotech leader Luba Greenwood to its Board as it scales its Same-Cell Biology platform to address a “causal data bottleneck” in AI-driven drug discovery. The update signals progress in leadership and platform development, but provides no quantified financial impact or near-term milestones.